BioBridgeXAll companies

Emulate, Inc.

Biotechnology company · Boston, Massachusetts, United States

Emulate, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $149,996 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $57 million sold in a notice filed in 2021.

emulatebio.comProfile compiled from public records. Is this your company? Request a correction or update

Emulate at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2013
Employees (self-reported, 2018)65
SEC CIK1614538

What does Emulate do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $149,996 in total (2018). NIH funding came from the National Institute on Alcohol Abuse and Alcoholism.

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $57.5 million sold (2021).

Frequently asked questions about Emulate

Where is Emulate headquartered?

Emulate, Inc. is headquartered in Boston, Massachusetts, United States.

What does Emulate do?

Emulate, Inc. is a biotechnology company.

When was Emulate founded?

The earliest incorporation on record for Emulate, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences